FCM
BSX icon

Fortis Capital Management’s Boston Scientific BSX Stock Holding History

Fortis Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Hold
0
– – – 103

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fortis Capital Management's BSX Position: Q2 2026 in Review

Fortis Capital Management increased its Boston Scientific (BSX) stake by 19% in Q2 2026, buying an estimated $872K and bringing the position to 102,754 shares worth $4.39M. The position accounts for 0.49% of the portfolio, ranked #52.

Fortis Capital Management first reported a position in BSX in Q2 2020 and has held it in 5 quarters since. The position peaked at $5.9M in Q3 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Fortis Capital Management held 102,754 shares of Boston Scientific worth $4.39M as of Q2 2026.
  • Fortis Capital Management bought 16,059 Boston Scientific shares in Q2 2026, an estimated $872K.
  • Boston Scientific made up 0.49% of Fortis Capital Management's portfolio in Q2 2026, its #52 holding.
  • Fortis Capital Management first reported a position in Boston Scientific in Q2 2020 and has held it in 5 quarters since.
  • Fortis Capital Management's Boston Scientific position peaked at $5.9M in Q3 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fortis Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.